menu search

ABT / Abbott: Wait For A Better Entry Point

Abbott: Wait For A Better Entry Point
The number of children and teenagers in the United States diagnosed with type 2 diabetes could rise by as much as 675% by 2060, which boosts the market. The dividend per share has risen steadily at 7.2% per year, and management is shareholder-friendly by buying back shares, further boosting the dividend per share. Read More
Posted: Jan 1 2023, 06:06
Author Name: Seeking Alpha
Views: 110514

ABT News  

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

By Zacks Investment Research
November 3, 2023

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store. more_horizontal

Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?

By Seeking Alpha
November 1, 2023

Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?

Thermo Fisher and Abbott are two of our key Healthcare holdings in our fund, and both are among our top 10 holdings overall. Abbott and Thermo Fisher more_horizontal

FDA issues warning letter to Abbott for probiotic products for infants

By Reuters
October 26, 2023

FDA issues warning letter to Abbott for probiotic products for infants

The U.S. Food and Drug Administration said on Thursday it has issued a warning letter to Abbott Laboratories for the company's probiotic products sold more_horizontal

ZBH or ABT: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 25, 2023

ZBH or ABT: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Zimmer Biomet (ZBH) or Abbott (ABT). But which of these tw more_horizontal

5 Stocks to Watch on Solid Revenues in Last Reported Quarter

By Zacks Investment Research
October 25, 2023

5 Stocks to Watch on Solid Revenues in Last Reported Quarter

We have narrowed our search to five U.S. corporate behemoths. These are: JPM, UNH, PG, ABT, FCX. more_horizontal

Are These 3 Dividend Aristocrats Undervalued Hidden Gems?

By MarketBeat
October 25, 2023

Are These 3 Dividend Aristocrats Undervalued Hidden Gems?

If you look at MarketBeat's list of dividend aristocrats, you'll see a select group of publicly traded companies that have an outstanding track record more_horizontal

Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.

By The Motley Fool
October 24, 2023

Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.

Abbott Laboratories' business has underwhelmed investors in 2023, as testing numbers are down big. Growth in its medical devices was the only bright s more_horizontal

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

By Zacks Investment Research
October 23, 2023

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store. more_horizontal


Search within

Pages Search Results: